Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
NCT06740383
This study is recruiting at 6 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizophrenia, Schizoaffective Disorder, and Bipolar I Disorder. It involves gathering mental health information, brain scans (MRI), eye movement patterns (Eye-Tracking), and brain electrical waves (EEG) data from individuals who have experienced these disorders in recent years. Participants will be involved for about a year, with four visits over this period.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Schizophrenia Spectrum and Other Psychotic Disorders
- Schizophrenia
- Delusional Disorder
- Bipolar 1 Disorder
- Schizoaffective Disorder
- Psychosis Not Otherwise Specified
- Early Psychosis
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Beth Israel Deaconess Medical Center
- Last updated on ClinicalTrials.gov
- March 10, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Connecticut · 1
- Hartford Hospital · Hartford, CT
Georgia · 1
- University of Georgia · Athens, GA
Illinois · 1
- University of Chicago Medical Center · Chicago, IL
Massachusetts · 2
- McLean Hospital · Belmont, MA
- Beth Israel Deaconess Medical Center · Boston, MA
Texas · 1
- University of Texas Southwestern Medical Center · Dallas, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.